Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.
Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.
At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.
We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.
For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.
Latest News:
- --- Source: Alphatec Holdings, Inc.
- ---
- ---
- Source: Spineology Inc.
- ---
- ---
Alphatec Holdings, Inc. (ATEC) reported a 35% increase in total revenue to $84 million for Q2 2022, with organic growth of 30%. The GAAP gross margin was 66%, and the company reported an operating loss of $36 million. Notably, EOS imaging contributed $12 million in revenue, a 49% growth. ATEC raised its full-year revenue guidance to $325 million, reflecting an anticipated 34% growth. The firm hosted over 150 surgeons, increasing users by 23%, alongside a 10% increase in average revenue per surgery.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will participate in several investor events, featuring CEO Pat Miles and CFO Todd Koning. Key events include the 42nd Annual Canaccord Genuity Growth Conference on August 10, 2022, and the 7th Annual Needham Virtual MedTech and Diagnostics 1x1 Conference on August 15, 2022. Additionally, they will join the Piper Sandler MedTech and Diagnostics West Coast Bus Tour and the RBC West Coast Medical Device Bus Tour, both on August 23, 2022. Webcasts of these events will be available in the Investor Relations Section of ATEC's website.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will report its second quarter 2022 financial results on August 4, 2022, after market close. A live webcast for this event will occur at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties can access the webcast through the Investor Relations Section of ATEC's website. Call-in details for participation will also be provided before the event.
Alphatec Holdings Inc. (Nasdaq: ATEC) is hosting an Investor Day at its headquarters in Carlsbad, CA, today from 8:15 a.m. to 12:00 p.m. PT. The event will showcase ATEC's commitment to transforming spine surgery and present the company’s financial outlook. A live webcast will be available on the Investor Relations section of ATEC's website, with a replay accessible post-event. ATEC aims to revolutionize spine surgery through innovative solutions and is dedicated to establishing itself as the standard bearer in the field.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announces participation in key investor events. CFO Todd Koning will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at 11:30 am PDT. Additionally, CEO Pat Miles and CFO Koning will attend the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022, at Terranea Resort in Rancho Palos Verdes, CA. ATEC focuses on innovative spine surgery solutions, driven by its Organic Innovation Machine, aiming to set a new standard in spine surgery.
Alphatec Holdings (ATEC) reported 61% revenue growth for Q1 2022, with total revenue reaching $71 million. Organic growth stood at 39%. The company generated over $10 million in EOS imaging revenue, contributing to an improved full-year guidance of $316 million, reflecting a 30% increase year-over-year. Operating expenses were noted at $90 million, leading to a GAAP operating loss of $41 million. ATEC emphasizes its focus on innovative technologies to enhance surgical outcomes and is poised for continued growth, showcasing an optimistic outlook for the future.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will report its first quarter 2022 financial results on May 5, 2022, after market close. A live webcast will take place at 1:30 p.m. PT / 4:30 p.m. ET. The event can be accessed via the Investor Relations Section of ATEC’s website.
Replays will be available for twelve months, with dial-in options for two hours post-webcast until May 12, 2022.
Alphatec Holdings Inc. (Nasdaq: ATEC) announced an Investor Day scheduled for May 25, 2022, from 8:00 a.m. PT to 12:00 p.m. PT at its headquarters in Carlsbad, CA. This event aims to showcase ATEC's innovative strategies in spine surgery, address market opportunities, and outline its long-term financial outlook. A live webcast will begin at 8:15 a.m. PT, allowing registered participants to submit questions. A replay will be available post-event. For registration and further details, visit the Investor Relations Section of ATEC's website.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced that Pat Miles, Chairman and CEO, and Todd Koning, CFO, will present at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022, at 11:45 am ET. A webcast and an archived recording of the presentation will be available in the Investor Relations Section of the company’s website. Alphatec is focused on innovative spine surgery solutions and aims to be the Standard Bearer in Spine through its Organic Innovation Machine™ and the AlphaInformatiX Platform.
Alphatec Holdings, Inc. (ATEC) reported a 68% revenue growth for 2021, with total revenue reaching $243.2 million and Q4 revenue at $74 million. Organic growth in the U.S. was 50%, with a 3-year CAGR of 36%. The GAAP gross margin stood at 64.9%, while operating expenses totaled $285.8 million. ATEC expects 2022 revenue to approximate $305 million, marking a 25% increase. EOS imaging-related revenue contributed $12.8 million. The company trained over 400 surgeons in 2021, enhancing its market presence.
FAQ
What is the current stock price of Alphatec Holdings (ATEC)?
What is the market cap of Alphatec Holdings (ATEC)?
What does Alphatec Holdings, Inc. specialize in?
What are some of the key technologies developed by Alphatec Spine?
How does Alphatec Holdings, Inc. improve spine surgery procedures?
What is the mission of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. drive growth?
Where can I find more information about Alphatec Holdings, Inc.?
What recent achievements has Alphatec Holdings, Inc. made?
What are the main products of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. ensure superior patient outcomes?
Is Alphatec Holdings, Inc. involved in any partnerships?
